Related Experiment Videos

Inhibition of ras-induced proliferation and cellular transformation by p16INK4

M Serrano1, E Gómez-Lahoz, R A DePinho

  • 1Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, NY 11724.

Science (New York, N.Y.)
|January 13, 1995
PubMed

Insights

The protein p16INK4 inhibits cell growth by blocking the cell cycle. It acts as a tumor suppressor by preventing cell proliferation, as demonstrated in experiments with oncogenic proteins.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cyclin-dependent kinase 4 (CDK4) is a key regulator of the G1 phase in the cell cycle.
  • CDK4 activity is modulated by D-type cyclins (activating) and p16INK4 (inhibitory).

Purpose of the Study:

  • To investigate the inhibitory role of p16INK4 in cell cycle progression and cellular transformation.
  • To provide direct evidence for p16INK4's function as a cell growth inhibitor.

Main Methods:

  • Utilized ectopic expression of p16INK4 in primary rat embryo fibroblasts.
  • Assessed the effects of p16INK4 on cell cycle entry (S phase) induced by oncogenic Ha-Ras.
  • Examined the impact of p16INK4 on cellular transformation mediated by oncogenic Ha-Ras/Myc and Ha-Ras/E1a.

Main Results:

  • Ectopic p16INK4 expression blocked G1 to S phase transition induced by oncogenic Ha-Ras.
  • This cell cycle block was reversible with a catalytically inactive CDK4 mutant.
  • p16INK4 suppressed cellular transformation by Ha-Ras/Myc but not by Ha-Ras/E1a.

Conclusions:

  • p16INK4 directly inhibits cell growth by regulating cell cycle progression.
  • p16INK4 functions as a tumor suppressor, with its efficacy potentially dependent on other viral oncoproteins.

Related Concept Videos